Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Creatine does not cause hair loss.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Age, diabetes, and cardiogenic shock at PCI are key factors linked to in-hospital death in STEMI patients with hypertension.

Gefitinib can cause scalp skin issues and permanent hair loss.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

A new method can detect mutations in mice by observing changes in hair follicle cells.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

The keratin 5 mutation in a family with epidermolysis bullosa simplex was due to mosaicism, not a new mutation.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.